ISTH/LinkedIn
Oct 3, 2025, 12:30
ISTH: Advancing Hemophilia Treatment Today and Tomorrow
International Society on Thrombosis and Haemostasis (ISTH) shared a post on LinkedIn:
“New CME opportunity! The hemophilia treatment landscape is rapidly evolving — are you up to date?
Our latest expert-led module, Updates in FVIIa Mimetics: Advancing Hemophilia Treatment Today and Tomorrow, is designed for hematology care teams including physicians, NPs, PAs, nurses and pharmacists.
What you’ll get:
- Key insights into emerging therapies
- Clinical trial updates
- Best practices to individualize patient care”
Start learning today here
Stay updated with Hemostasis Today.
-
Jan 16, 2026, 05:52Piotr Czempik Shares His Latest Contribution to Acta Haematologica Polonic
-
Jan 16, 2026, 05:44Florian Piekarski on Perioperative Blood Management When Allogeneic Transfusion is Not Aaccepted
-
Jan 16, 2026, 05:00Plaque Rupture and Thrombosis
-
Jan 16, 2026, 04:52Arterial Disease Across Vascular Beds․ Lipoprotein(a) as a Causal Risk Factor
-
Jan 16, 2026, 04:51Higher-Dose Clotting Factor Prophylaxis Does Not Reduce Postpartum Hemorrhage in Women with von Willebrand Disease
-
Jan 16, 2026, 04:48Reza Shojaei on Plasma Donation as Life-Changing Medicine in Motion
-
Jan 16, 2026, 04:11Open-Label Extension Study of Marstacimab: Pfizer Has Reported a Fatal Event
-
Jan 16, 2026, 04:11Why is DVT More Common In the Left Leg? Dr Raheel Moazzam’s New Study Gives Answers!
-
Jan 15, 2026, 22:00Maira Dastgir N on Microvascular Dysfunction in Geriatrics